Zoetis Inc (ZTS)
Zoetis Market Cap: 79.42B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 79.42B |
May 16, 2024 | 79.26B |
May 15, 2024 | 79.07B |
May 14, 2024 | 77.05B |
May 13, 2024 | 76.62B |
May 10, 2024 | 77.13B |
May 09, 2024 | 76.72B |
May 08, 2024 | 75.25B |
May 07, 2024 | 76.86B |
May 06, 2024 | 75.72B |
May 03, 2024 | 76.23B |
May 02, 2024 | 76.31B |
May 01, 2024 | 72.32B |
April 30, 2024 | 72.66B |
April 29, 2024 | 72.87B |
April 26, 2024 | 72.29B |
April 25, 2024 | 70.08B |
April 24, 2024 | 68.94B |
April 23, 2024 | 68.34B |
April 22, 2024 | 66.50B |
April 19, 2024 | 66.94B |
April 18, 2024 | 69.96B |
April 17, 2024 | 69.43B |
April 16, 2024 | 69.92B |
April 15, 2024 | 68.44B |
Date | Value |
---|---|
April 12, 2024 | 68.53B |
April 11, 2024 | 74.36B |
April 10, 2024 | 74.57B |
April 09, 2024 | 76.37B |
April 08, 2024 | 75.71B |
April 05, 2024 | 75.79B |
April 04, 2024 | 75.63B |
April 03, 2024 | 74.47B |
April 02, 2024 | 75.40B |
April 01, 2024 | 76.32B |
March 28, 2024 | 77.32B |
March 27, 2024 | 77.07B |
March 26, 2024 | 75.77B |
March 25, 2024 | 76.75B |
March 22, 2024 | 77.25B |
March 21, 2024 | 76.98B |
March 20, 2024 | 78.20B |
March 19, 2024 | 79.10B |
March 18, 2024 | 78.07B |
March 15, 2024 | 78.93B |
March 14, 2024 | 79.53B |
March 13, 2024 | 80.60B |
March 12, 2024 | 82.94B |
March 11, 2024 | 83.92B |
March 08, 2024 | 83.41B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
IDEXX Laboratories Inc | 44.88B |
Pfizer Inc | 162.29B |
ResMed Inc | 32.11B |
Amgen Inc | 167.62B |
Biogen Inc | 33.57B |
Market Cap Related Metrics
PE Ratio | 33.54 |
PS Ratio | 9.183 |
PEG Ratio | 1.955 |
Price to Book Value | 15.70 |
Price to Free Cash Flow | 45.83 |
Price | 174.02 |
Earnings Yield | 2.98% |
PEGY Ratio | 1.855 |
Operating PE Ratio | 25.53 |
Normalized PE Ratio | 33.18 |